BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23344397)

  • 1. Management of uterine bleeding during hematopoietic stem cell transplantation.
    Purisch SE; Shanis D; Zerbe C; Merideth M; Cuellar-Rodriguez J; Stratton P
    Obstet Gynecol; 2013 Feb; 121(2 Pt 2 Suppl 1):424-7. PubMed ID: 23344397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The medical management of abnormal uterine bleeding in reproductive-aged women.
    Bradley LD; Gueye NA
    Am J Obstet Gynecol; 2016 Jan; 214(1):31-44. PubMed ID: 26254516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guideline No. 389-Medical Management of Symptomatic Uterine Leiomyomas - An Addendum.
    Laberge PY; Murji A; Vilos GA; Allaire C; Leyland N; Singh SS
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1521-1524. PubMed ID: 31548041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple therapies for vaginal bleeding secondary to large uterine myomas.
    Thomas MA; Gass ML; Scott MC; Liu JH
    Int J Gynaecol Obstet; 1991 Nov; 36(3):239-41. PubMed ID: 1685460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations.
    Mir MA; Kochuparambil ST; Abraham RS; Rodriguez V; Howard M; Hsu AP; Jackson AE; Holland SM; Patnaik MM
    Cancer Med; 2015 Apr; 4(4):490-9. PubMed ID: 25619630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic hematopoietic cell transplantation in patients with GATA2 deficiency-a case report and comprehensive review of the literature.
    Simonis A; Fux M; Nair G; Mueller NJ; Haralambieva E; Pabst T; Pachlopnik Schmid J; Schmidt A; Schanz U; Manz MG; Müller AMS
    Ann Hematol; 2018 Oct; 97(10):1961-1973. PubMed ID: 29947977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Compared With Leuprorelin Injections for Uterine Leiomyomas: A Randomized Controlled Trial.
    Osuga Y; Enya K; Kudou K; Tanimoto M; Hoshiai H
    Obstet Gynecol; 2019 Mar; 133(3):423-433. PubMed ID: 30741797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of menorrhagia in women undergoing hematopoietic stem cell transplantation.
    Amsterdam A; Jakubowski A; Castro-Malaspina H; Baxi E; Kauff N; Krychman M; Stier E; Castiel M
    Bone Marrow Transplant; 2004 Aug; 34(4):363-6. PubMed ID: 15195079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aborted leiomyosarcoma after treatment with leuprolide acetate.
    Mesia AF; Williams FS; Yan Z; Mittal K
    Obstet Gynecol; 1998 Oct; 92(4 Pt 2):664-6. PubMed ID: 9764655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and GnRH action. Report of a case with contribution by peripherally derived estrogens.
    Hansen LM; Batzer FR; Corson SL; Bello S
    J Reprod Med; 1997 Apr; 42(4):247-50. PubMed ID: 9131500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical management of uterine fibroids with medroxyprogesterone acetate (Depo Provera): a pilot study.
    Venkatachalam S; Bagratee JS; Moodley J
    J Obstet Gynaecol; 2004 Oct; 24(7):798-800. PubMed ID: 15763792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of menorrhagia associated with chemotherapy-induced thrombocytopenia in women with hematologic malignancy.
    Bates JS; Buie LW; Woodis CB
    Pharmacotherapy; 2011 Nov; 31(11):1092-110. PubMed ID: 22026397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GATA2 and marrow failure.
    Fabozzi F; Strocchio L; Mastronuzzi A; Merli P
    Best Pract Res Clin Haematol; 2021 Jun; 34(2):101278. PubMed ID: 34404529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-derived myelodysplastic syndrome after allogeneic stem cell transplantation in a family with germline GATA2 mutation.
    Sakata N; Okano M; Masako R; Tanaka A; Yamashita Y; Karasuno T; Imadome KI; Okada M; Sugimoto K
    Int J Hematol; 2021 Feb; 113(2):290-296. PubMed ID: 32865708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal hemorrhage associated with degenerating submucous leiomyomata during leuprolide acetate treatment.
    Friedman AJ
    Fertil Steril; 1989 Jul; 52(1):152-4. PubMed ID: 2501108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of tranexamic acid in management of dysfunctional uterine bleeding in comparison with medroxyprogesterone acetate.
    Kriplani A; Kulshrestha V; Agarwal N; Diwakar S
    J Obstet Gynaecol; 2006 Oct; 26(7):673-8. PubMed ID: 17071438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gynaecological and obstetric management of women with inherited bleeding disorders.
    Demers C; Derzko C; David M; Douglas J;
    J Obstet Gynaecol Can; 2005 Jul; 27(7):707-32. PubMed ID: 16100628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depo medroxyprogesterone acetate (DMPA) therapy for uterine myomata prior to surgery.
    Johnson N; Fletcher H; Reid M
    Int J Gynaecol Obstet; 2004 May; 85(2):174-6. PubMed ID: 15099785
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic amenorrhea in hematologic disorders.
    Laros RK
    Obstet Gynecol; 1971 Oct; 38(4):589-93. PubMed ID: 5107182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal expulsion of submucosal fibroids after uterine artery embolization. A report of three cases.
    Berkowitz RP; Hutchins FL; Worthington-Kirsch RL
    J Reprod Med; 1999 Apr; 44(4):373-6. PubMed ID: 10319310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.